Albireo Pharma
Albireo is a Clinical Stage Biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases and other adult liver diseases and disorders. The company annual revenue is 8.3 million USD and 55 employees as on 2020. The headquarters is in USA.